Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Saint Vincent Hospital in Worcester, Massachusetts, may lose its Medicare funding because of safety and patient identification issues, including a very damaging mistake made by one surgeon.
The U.S. Food and Drug Administration (FDA) has awarded 21 clinical trail grants, totaling more than $23 million, for the advancement of products for patients with rare diseases. These grants were given to lead academic investigators and industries with both domestic and international research clinics.
The increasing prevalence of high-deductible health plans among insurers can cause headaches for a clinical practice, with physicians feeling stuck when they recommend care not covered by a patient's policy.
Blue Cross Blue Shield of Texas will soon offer more benefits to families with children suffering from complex and demanding conditions, such as mental health disease or drug and alcohol addiction.
Rational Vaccines, a biotechnology company and leaders in herpes research, have finished their Phase I Clinical Trial of the Theravax vaccine for patients with herpes simplex virus 1 and 2 (HSV-1, HSV-2). Results found that this medication may be the “functional cure” for both diseases.
Twitter has quickly become the most used application among adults aged 18 to 49 for hashtagging what we are doing, but who knew our tweets could tell us about our eating habits? Researchers from the University of Utah found that tweets about healthier food and more exercise come from neighborhoods that were found to be healthier.
HemaTerra Technologies, providers of software to healthcare facilities handling blood and other biologic products, has launched HemaComply–Equipment Manager, an equipment maintenance and quality control scheduling system made especially for facilities that handle blood.
As STAT News puts it, University of Utah Health Care CEO Vivian Lee, MD, PhD, MBA, is looking for a revolution in healthcare, and it all starts with asking patients one question: What do you want from your care?
CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
